Previous 10 | Next 10 |
2023-03-29 21:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-03-20 06:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-03-15 12:51:03 ET PAVmed Inc. (PAVM) Q4 2022 Earnings Conference Call March 15, 2023 8:30 AM ET Company Participants Michael Parks – Vice President, Investor Relations Lishan Aklog – Chairman and CEO Dennis McGrath – Chief Financial Offi...
2023-03-15 12:00:12 ET The following slide deck was published by PAVmed Inc. in conjunction with their 2022 Q4 earnings call. For further details see: PAVmed Inc. 2022 Q4 - Results - Earnings Call Presentation
2023-03-15 11:26:43 ET PAVmed ( NASDAQ: PAVM ) stock fell ~9% following its Q4 results. Non-GAAP adjusted loss was -$0.15, same as in Q4 2021. Net loss widened to -$24.57M, compared to -$19.68M in Q4 2021. Revenue (EsoGuard related revenues) declined -62.6% Y/Y...
2023-03-13 18:35:29 ET PAVmed ( NASDAQ: PAVM ) is scheduled to announce Q4 earnings results on Tuesday, March 14th, after market close. The consensus EPS Estimate is -$0.21 (vs. -$0.15 in year ago quarter) and the consensus Revenue Estimate is $0.28M (compared to $300M in ...
Lucid Diagnostics Provides Business Update and Fourth Quarter and Full Year 2022 Financial Results PR Newswire 4Q22 and projected 1Q23 EsoGuard ® test volume increases 8 and 36 percent sequentially and 288 and 300 percent annually. Company signs in-network agreement...
2023-03-10 14:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 14, 2023 PR Newswire Conference Call and Webcast at 8:30AM Eastern Time NEW YORK , March 3, 2023 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid...
PAVmed to Hold a Business Update Conference Call and Webcast on March 15, 2023 PR Newswire Conference Call and Webcast at 8:30AM Eastern Time NEW YORK , March 3, 2023 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed" or the "Company"...
News, Short Squeeze, Breakout and More Instantly...
Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume PR Newswire Quarterly EsoGuard ® test volume increased 31 percent sequentially NEW YORK , July 23, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("L...
Lucid Diagnostics Launches New Corporate Website PR Newswire NEW YORK , July 11, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and majority-ow...
Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population PR Newswire Prospective screening study demonstrates excellent EsoGuard s...